Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC4XD.L Share News (C4XD)

  • There is currently no data for C4XD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

Wed, 03rd Jan 2024 10:12

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

C4X Discovery Holdings PLC, up 34% at 11.75 pence, 12-month range 7.63p-22.00p. The drug discovery company focussed on immuno-inflammatory diseases receives a USD11.0 million milestone payment from FTSE 100-listed pharmaceutical firm AstraZeneca PLC, following trials of the C4X respiratory disease therapy treatment. The payment stems from preclinical progress of C4X's NRF2 Activator programme, an oral therapy for the treatment of inflammatory and respiratory diseases which AstraZeneca is developing following a agreement between the two in November. In addition to a USD2.0 million upfront payment, the global licencing agreement for the NRF2 Activator entitles C4X to receive up to USD400.0 million in payments following preclinical, clinical development and commercial milestones. The deal also will grant C4X tiered mid-single digit royalties on future sales of the NRF2.

----------

Getech Group PLC, up 29% at 6.75p, 12-month range 4.10p-17.43p. The geo-energy and green hydrogen company says it has won eight new contracts, worth GBP1.8 million in total. The deals comprise of subscriptions to Getech's Globe platform, geoscience data and the purchase of expert consulting services. It expects to recognise GBP600,000 of revenue from these contracts in its 2023 earnings. Acting Chief Executive Officer Richard Bennett says: "Entering 2024 with our substantially reduced costbase, increased order book and growing [annual recurring revenue] means the business is undoubtedly better placed following a year of transition in 2023. We have also invested in expanding our exploration capabilities, targeting resources associated with the energy transition. The recent Cop28 demonstrated again the world's commitment to phasing down fossil fuels and in 2024 we expect to benefit from this by helping our customers locate the subsurface future facing resources such as critical minerals and geothermal projects that are so vital to the energy transition."

----------

AIM - LOSERS

----------

Mkango Resources Ltd, down 7.3% at 9.50p, 12-month range 8.00p-17.41p. The mineral exploration and development company says that its subsidiary Maginito Ltd will partner with CoTec Holdings Corp to roll out scrap magnetic recycling technology in the US. The partnership will focus on promoting HyProMag Ltd's technology. HyProMag is a rare earth magnet recycling company in which Maginito holds a 100% stake, and is commercialising its technology in the UK, Germany and US. The 50-50 joint venture will initially involve a bankable feasibility study using three hydrogen processing of magnet scrap vessels and a magnet manufacturing hub. Following this, Mkango and CoTec will decide whether to proceed with the construction of the US project. Revenue from the project is targeted for either 2025 or 2026. The pair recently issued a request for proposal process from "leading engineering, procurement and construction management providers", and has ordered three HPMS reactors to expedite the US project.

----------

By Greg Rosenvinge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
2 Dec 2021 16:32

EXECUTIVE CHANGES: Oil exec Dev Sanyal moves to M&G board from Man

EXECUTIVE CHANGES: Oil exec Dev Sanyal moves to M&G board from Man

Read more
19 Nov 2021 14:56

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

Read more
29 Apr 2021 17:33

TRADING UPDATES: Keystone Law and Checkit post annual revenue growth

TRADING UPDATES: Keystone Law and Checkit post annual revenue growth

Read more
22 Apr 2021 16:10

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Apr 2021 15:36

EXECUTIVE CHANGES: James Fisher names new CFO; Lekoil loses new chair

EXECUTIVE CHANGES: James Fisher names new CFO; Lekoil loses new chair

Read more
12 Apr 2021 11:28

AIM WINNERS & LOSERS: Touchstone up on gas find, C4X on Sanofi deal

AIM WINNERS & LOSERS: Touchstone up on gas find, C4X on Sanofi deal

Read more
12 Apr 2021 11:06

C4X Discovery secures EUR414 million licensing deal with Sanofi

C4X Discovery secures EUR414 million licensing deal with Sanofi

Read more
12 Apr 2021 08:41

C4X Discovery signs exclusive licensing deal with Sanofi

(Sharecast News) - C4X Discovery has signed an exclusive worldwide licensing agreement with Sanofi worth up to €414m (£357.84m), it announced on Monday, for its oral preclinical IL-17A inhibitor programme.

Read more
10 Dec 2020 17:07

UK EARNINGS SUMMARY: Character Group Lowers Dividend As Profit Drops

UK EARNINGS SUMMARY: Character Group Lowers Dividend As Profit Drops

Read more
8 Dec 2020 17:20

UK EXECUTIVE CHANGE SUMMARY: Impax AM's Long-Serving Chair Retires

UK EXECUTIVE CHANGE SUMMARY: Impax AM's Long-Serving Chair Retires

Read more
8 Dec 2020 12:26

C4X Discovery CEO to be interim chair of UK Vaccine Taskforce

(Sharecast News) - Drug discovery company C4X Discovery confirmed on Tuesday that its chief executive officer Clive Dix has stepped into the role of interim chair of the UK Vaccine Taskforce.

Read more
22 Oct 2020 20:33

IN BRIEF: Adams Invests GBP700,000 In C4X Discovery's Fund Raise

IN BRIEF: Adams Invests GBP700,000 In C4X Discovery's Fund Raise

Read more
21 Oct 2020 16:12

IN BRIEF: C4X Discovery Raises GBP15 Million Through Share Placing

IN BRIEF: C4X Discovery Raises GBP15 Million Through Share Placing

Read more
25 Aug 2020 12:28

C4X Discovery Joins Covid Collaboration With Italian Hospitals

C4X Discovery Joins Covid Collaboration With Italian Hospitals

Read more
5 Jun 2020 13:01

UK TRADING UPDATE SUMMARY: C4X Boss Appointed To UK Vaccine Taskforce

UK TRADING UPDATE SUMMARY: C4X Boss Appointed To UK Vaccine Taskforce

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.